Clinical trial
Investigating the Effects of Varenicline on D2/3 Receptor Binding in Brain of Tobacco-smokers: a PET/[11C](+)PHNO Study
NCT01632189 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating the Effects of Varenicline on D2/3 Receptor Binding in Brain of Tobacco-smokers: a PET/[11C](+)PHNO Study
- Lead sponsor
- Centre for Addiction and Mental Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- August 31, 2015
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nicotine dependence